Comera Life Sciences (CMRA) Form 3 Comera Life Sciences / Shameek Konar ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Konar Shameek

(Last) (First) (Middle)

10608 STOPPARD VIEW WAY

(Street)

KNOXVILLE TN 37922

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
12/27/2023

3. Issuer Name and Ticker or Trading Symbol
Comera Life Sciences Holdings, Inc. [ CMRA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
Member of 10% owner group

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

	Form filed by One Reporting Person
X	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	1,001,064	I	By Regolith Capital Investments, L.P.(1)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrants to Purchase Common Stock	02/01/2024	07/31/2028	Common Stock	1,198,044	0.6135	I	By Regolith Capital Investments, L.P.(1)
Warrants to Purchase Common Stock	09/11/2023	09/11/2028	Common Stock	513,447	0.6135	I	By Regolith Capital Investments, L.P.(1)

1. Name and Address of Reporting Person^*

Konar Shameek

(Last) (First) (Middle)

10608 STOPPARD VIEW WAY

(Street)

KNOXVILLE TN 37922

(City) (State) (Zip)

1. Name and Address of Reporting Person^*

Konar Victoria

(Last) (First) (Middle)

10608 STOPPARD VIEW WAY

(Street)

KNOXVILLE TN 37922

(City) (State) (Zip)

Explanation of Responses:

1. The reporting persons are general partners of Regolith Capital Investments, L.P. ("Regolith") and disclaim beneficial ownership of the securities held by Regolith except to the extent of their pecuniary interest therein

	/s/ Shameek Konar	02/02/2024
	/s/ Victoria Konar	02/02/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.